State Of Wisconsin Investment Board Galectin Therapeutics Inc Transaction History

State Of Wisconsin Investment Board

  • $37.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 06, 2020
SELL
$1.51 - $3.0 $91,657 - $182,100
-60,700 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$2.79 - $4.32 $25,461 - $39,424
9,126 Added 17.69%
60,700 $174,000
Q3 2019

Nov 12, 2019
BUY
$3.0 - $4.05 $154,722 - $208,874
51,574 New
51,574 $189,000

Others Institutions Holding GALT

# of Institutions
91
Shares Held
9.65M
Call Options Held
1.16M
Put Options Held
1.98M
View Full List

About GALECTIN THERAPEUTICS INC

GALT Quotes by TradingView
  • Ticker GALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,426,000
  • Market Cap $171M
  • Description
  • Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...
More about GALT
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email